Financings Routine −

Grey Matters Announces Private Placement

Grey Matters Health Raises Capital at Discount to Fund US Clinic Expansion Amidst Dilution Concerns

By The Northwire Desk — AI Analysis Apr 22, 2026 · 07:00 GREY · 0.495 Grey Matters Health Inc.

Executive Summary

Grey Matters Health Inc. announced a non-brokered private placement on 2026-04-22.
The offering targets gross proceeds of CAD $1,000,000.
Units are priced at CAD $0.40 per unit, representing a 20% discount to the previous trading day's close of $0.50.
Proceeds are designated for advancing the Alzheimer’s Disease program and opening the first U.S.-based neuroimaging clinic.
General working capital and administrative expenses will also be funded by this raise.
Each unit includes one Class A common share and one Common Share purchase warrant.
Warrants have an exercise price of CAD $0.60 with a 24-month expiry, subject to acceleration if the stock trades above $0.80 for 10 consecutive days.
Finder's fees up to 8% of proceeds may be paid in cash or finders warrants.

Material Impact

The financing is dilutive to existing shareholders due to the issuance of new shares and warrants at a discount to market price.
A 20% discount ($0.40 vs $0.50) signals potential weakness or an urgent need for liquidity, which typically suppresses stock sentiment in the short term.
The capital raise amount ($1M CAD) is relatively small; while it extends runway, it may not be sufficient to fully fund a U.S. clinic opening without further financing rounds later.
Warrants introduce future dilution risk if the share price recovers above $0.60, though they are currently out-of-the-money relative to the previous close ($0.50).
The acceleration clause creates an incentive for management to drive share price volatility or positive news to trigger warrant expiry, potentially increasing float pressure in 24 months.
Given the lack of historical financial data, it is unclear if this capital is a lifeline against insolvency or simply operational expansion; risk aversion suggests caution regarding cash burn rates.

GREY · Price

Company Overview

Company: Grey Matters Health Inc.
Flagship Project: Alzheimer’s Disease program focusing on neuroimaging.
Development Stage: Advancing towards opening a first U.S.-based brain-specific neuroimaging clinic.
Business Model: Likely service-based or diagnostic imaging focused on neurological conditions, specifically dementia/Alzheimer's.
Strategic Focus: Expansion into the U.S. market from its current base (likely Canada given CAD currency).

More from Grey Matters Health Inc.